Sanara MedTech Inc.
PosiFunda Ratios Only on PositoAI
PositoAI's own ratios from Sanara MedTech Inc.'s yearly results (2022–2025), compared with Healthcare companies in United States. Tap ? on any ratio for what it means.
What stands out
- Tangible Net Worth Ratio: Goodwill and other intangibles are larger than its whole net worth, so its tangible net worth is negative. Less tangible than 96% of Healthcare companies in United States.
- Debt Due Cover Ratio: Debt due within a year is covered 19.2 times by its yearly operating cash. Higher than 89% of Healthcare companies in United States.
Where $100 of sales goes
Latest year (Dec 2025). Taxes and other income are not shown, so the parts need not add up to 100.
Cash quality
Profit Cash Ratio
—Loss-making or profit too small
Over the last 3 years profit was a loss or under 2% of sales, so cash per 100 of profit is not meaningful.
Self-Funding Ratio
0.7×Over the last 3 years its own operating cash paid for 68% of its investment spending (capex); the rest came from other sources such as borrowing, cash reserves or new shares.
Higher than 66% of Healthcare companies in United States.
Cash Locked Ratio
$13For every $100 of sales, $13 is tied up in day-to-day operations (money owed by customers + stock − money owed to suppliers), against $20 tied up three years earlier.
Less money tied up than 72% of Healthcare companies in United States.
Growth quality
Steadiness Ratio
3/3 · 1/3Sales grew in 3 of the last 3 years; profit grew in 1 of 3.
Steadier than 69% of Healthcare companies in United States.
Growth Efficiency Ratio
−$52Sales grew 125% in 3 years, but profit fell: $52 less profit per $100 of extra sales.
Lower than 83% of Healthcare companies in United States.
Asset Productivity Ratio
+125% / +20%In 3 years sales changed by +125% while total assets changed by +20%. Sales grew faster than assets.
Balance-sheet strength
Debt Due Cover Ratio
19.2×Debt due within a year is covered 19.2 times by its yearly operating cash.
Higher than 89% of Healthcare companies in United States.
Cash Cushion Ratio
−10%Debt, after subtracting cash, equals 10% of its market value (net debt).
Lower than 79% of Healthcare companies in United States.
Tangible Assets Ratio
70%Of every $100 the company owns, $70 is in tangible assets such as plants, cash, stock and receivables; the rest is goodwill and other intangibles.
Less tangible than 62% of Healthcare companies in United States.
Tangible Net Worth Ratio
NegativeGoodwill and other intangibles are larger than its whole net worth, so its tangible net worth is negative.
Less tangible than 96% of Healthcare companies in United States.
Shareholders
Standard fundamentals
P/E, P/B, ROE, debt, growth and more (13)
Sanara MedTech Inc. made a loss over the last year. Sanara MedTech Inc. owes $0.89 for every $1 it owns. Sanara MedTech Inc. made a loss in each of the last two years.
Compared with Healthcare companies in United States · latest annual results Dec 2025.
P/E ratio
LossSanara MedTech Inc. made a loss over the last year, so its P/E ratio is not meaningful.
P/B ratio
38.03The share price is 38.03 times Sanara MedTech Inc.'s book value per share, higher than 98% of Healthcare companies in United States.
Market cap
$302 MThe total market value of all of Sanara MedTech Inc.'s shares at today's price (share price × number of shares), smaller than 52% of Healthcare companies in United States. PosiCap size class: Mini Cap.
Net worth (book value)
$8 MWhat Sanara MedTech Inc. would have left on paper if it sold everything it owns and paid everything it owes, from its latest balance sheet (30 Jun 2026).
Book value per share
$0.86Net worth divided by the number of shares. The share price of $32.88 is 38.0 times this, which is the P/B above.
Return on equity (ROE)
-1.3%Sanara MedTech Inc. lost 1.3% of its shareholders' money over the last year, higher than 75% of Healthcare companies in United States.
Owes vs Owns
0.89×Sanara MedTech Inc. owes $0.89 for every $1 it owns (high), higher than 82% of Healthcare companies in United States.
Dividend yield
NoneSanara MedTech Inc. does not currently pay a dividend.
Revenue growth
+19%Revenue rose 19% in the year to Dec 2025, and grew 31% a year on average over 3 years.
Profit growth
LossSanara MedTech Inc. made a loss in each of the last two years.
Profit margin
-36.4%Sanara MedTech Inc. lost $36 for every $100 of revenue.
Interest cover
1.4×Sanara MedTech Inc.'s operating profit covered its interest costs 1.4 times in the year to Dec 2025.
Cash vs debt
Net debtSanara MedTech Inc. had $32 M more debt than cash (net debt) at Dec 2025.
Questions
How is P/B calculated on PositoAI?
P/B is market cap divided by net worth from the latest balance sheet. For Sanara MedTech Inc.: $302 M ÷ $8 M (30 Jun 2026) = 38.0.
What is Sanara MedTech Inc.'s return on equity?
Sanara MedTech Inc. lost 1.3% of its shareholders' money over the last year, higher than 75% of Healthcare companies in United States.
How much does Sanara MedTech Inc. owe compared with what it owns?
Sanara MedTech Inc. owes $0.89 for every $1 it owns (high), higher than 82% of Healthcare companies in United States.
Does Sanara MedTech Inc. pay a dividend?
No. Sanara MedTech Inc. does not currently pay a dividend.
Is Sanara MedTech Inc.'s revenue growing?
Revenue rose 19% in the year to Dec 2025, and grew 31% a year on average over 3 years.
Figures from the company's yearly results and PositoAI's own data. Full tables are on the Go Deep tab. What each figure means. PositoAI is for research and education only and is not investment advice.